Breast Conservation in Patients with Multiple Ipsilateral Tumors
Judy C. Boughey, MD, associate professor of surgery, director, Breast Surgical Oncology Training Program, Mayo Clinic, discusses breast conservation in patients with multiple ipsilateral tumors.
Judy C. Boughey, MD, associate professor of surgery, director, Breast Surgical Oncology Training Program, Mayo Clinic, discusses breast conservation in patients with multiple ipsilateral tumors.
Clinical Pearls:
- A second or third focus of cancer is often found after women are initially diagnosed with breast cancer
- The recommendation for multiple ipsilateral tumors has historically been mastectomy
- A prospective clinical trial is currently ongoing that examines if these women still need to undergo mastectomy
- The patients in the study will receive a lumpectomy before being treated with radiation
Batalini Explores Role of UGT1A1 in Patients Treated With Sacituzumab Govitecan for HR+ MBC
April 22nd 2024During a Community Case Forum live event in partnership with The Arizona Clinical Oncology Society, Felipe Batalini, MD, discussed the TROPiCS-02 trial of sacituzumab govitecan and the impact of the UGT1A1 status on adverse event frequency.
Read More
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
